ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 683833 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 683833; 2) Community: the network communities that were significantly associated with the response to NSC 683833; 3) Molecule: the relationships between components within communities and NSC 683833; 4) MDR: the compounds that were significantly associated with the NSC 683833.

NSC Compound Enrichment Correlation
NSC 709440 Null 0.0385613993886001 0.21261398
NSC 71669 Null 0.0385613993886001 0.21140623
NSC 719715 Null 0.0385613993886001 0.25181293
NSC 722854 1,4-di-N-oxide-2-phenylcarbonyl-3-trifluoromethylquinoxaline 0.0385613993886001 0.2765591
NSC 727087 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.0385613993886001 0.066969666
NSC 740 Methotrexate 0.0385613993886001 0.30686964
NSC 743528 Null 0.0385613993886001 0.45714228
NSC 747461 Null 0.0385613993886001 -0.0033196487
NSC 754245 5-(2-(dimethylamino)ethyl)-2,8-dimethoxy-5H-indeno[1,2-c]quinoline-6,11-dione 0.0385613993886001 0.41208823
NSC 763059 Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride 0.0385613993886001 0.20784868
Total:88  Current:73    [First] [Prev] [Next] [Last]